NEI Fall Congress 2026: Program & Speakers
63 sessions across 5 days with 39 confirmed speakers — the program for NEI Fall Congress 2026, November 5–8, 2026 in Colorado Springs, CO. From the official program; excludes exhibits and social events.
Featured speakers: Adelaide S. Robb · Jeffrey Robert Strawn · Katherine K. Dahlsgaard · Timothy E. Wilens · Thomas L. Schwartz · Andrew J. Cutler · Kristian Dambrino · Stephen M. Stahl · Roger S. McIntyre · Christoph U. Correll · Jonathan M. Meyer · Hara E. Oyedeji · and 27 more below
No sessions match those filters. — or browse the full official program.
November 4, 2026
- 12:00–13:00SessionChild AcademyLunch Industry Session†: MDD & Me: An educational experience about an adjunctive treatment option through a hypothetical patient journey
Industry-sponsored lunch session following a hypothetical patient journey to illustrate an adjunctive treatment option for major depressive disorder.
- 13:15–18:00CoursePre-Conference ProgramsChild & Adolescent Psychiatry Academy
Pre-conference academy focused on child and adolescent psychiatry, offered ahead of the main NEI Fall Congress program.
- 15:35–15:55PanelChild AcademyPanel Q&A
Adelaide S. Robb · Jeffrey Robert Strawn · Katherine K. Dahlsgaard
Faculty panel answering audience questions on the preceding child and adolescent psychiatry talks.
- SymposiumChild & Adolescent Psychiatry AcademyYou Need to Calm Down: Addressing Irritability and Emotional Dysregulation in Youth With Autism Spectrum Disorder
Approaches to managing irritability and emotional dysregulation in children and adolescents with autism spectrum disorder.
- SymposiumChild & Adolescent Psychiatry AcademyShould I Stay or Should I Go? Using Dopamine Receptor Blocking Agents in Pediatrics
Weighs when to start, continue, or stop dopamine receptor blocking agents in pediatric patients, including safety and monitoring considerations.
Antipsychotic PrescribingChild & AdolescentDrug Interactions & Safety
- SymposiumChild & Adolescent Psychiatry AcademyUnder Pressure: Addressing Picky, Restricted, or Disordered Eating in Children and Adolescents
Clinical strategies for evaluating and treating picky, restrictive, and disordered eating patterns in youth.
- SymposiumChild & Adolescent Psychiatry AcademyDon't You Worry Child: Practical and Evidence-Based Care of Pediatric Anxiety
Jeffrey Robert Strawn · Katherine K. Dahlsgaard
Recognition, assessment, and evidence-based pharmacologic and psychotherapeutic management of anxiety disorders in children and adolescents.
- SymposiumChild & Adolescent Psychiatry AcademyI Still Haven't Found What I'm Looking For: Practical ADHD Management in Complex Cases
Managing ADHD complicated by executive dysfunction and psychiatric comorbidity, with practical treatment-optimization tactics.
November 5, 2026
- 07:00–08:00SessionPre-Conference Workshop: SleepBreakfast Industry Session†: Cracking the Code: Distinguishing the Phenomenology of Tardive Dyskinesia from Other Drug-Induced Movement Disorders
Industry-sponsored session on telling tardive dyskinesia apart from other drug-induced movement disorders based on clinical phenomenology.
- 10:50–11:10PanelPre-Conference Workshop: SleepPanel Q&A
Thomas L. Schwartz · Chelsie Monroe
Faculty question-and-answer panel following the sleep workshop presentations.
- 11:30–12:30SessionLunch Industry Session†: Clinical and Real-World Evidence: A Comprehensive Perspective in MDD (adjunctive) Patients and Bipolar I Patients
Industry-sponsored review of clinical trial and real-world evidence in adjunctive MDD and bipolar I disorder.
- 11:30–12:30SessionLunch Industry Session†: The Expert Exchange: Long-Acting Injectable Therapy in Schizophrenia—Data, Debate, and Clinical Decision-Making
Jonathan M. Meyer · Amber Hoberg
Industry-sponsored discussion of data and decision-making for long-acting injectable therapy in schizophrenia.
- 14:25–15:10LectureThe Mania Event: Unmet Needs, Treatment Challenges, and Emerging Pharmacotherapies in Bipolar Disorder
Roger S. McIntyre · Andrew J. Cutler
Examines unmet needs in treating acute mania, including mixed features, and evaluates emerging therapies such as recent lumateperone phase 3 data. Uses cases to illustrate individualized decisions.
- 15:10–15:30PanelMood Disorders Panel Q&A
Andrew J. Cutler · Kristian Dambrino · Stephen M. Stahl · Roger S. McIntyre
Faculty panel discussion on mood disorder topics from the preceding talks.
- 15:40–16:25SessionAfternoon Industry Session†: Learn More About This Long-Acting Injectable Option for Schizophrenia Treatment in Adults
Industry-sponsored session on a long-acting injectable option for adults with schizophrenia.
- 18:15–18:35PanelSMI Panel Q&A
Stephen M. Stahl · Christoph U. Correll
Faculty panel discussion following the serious mental illness talks.
- 18:45–19:45SessionDinner Industry Session†: Expanding our view for ADHD
Industry-sponsored dinner session on broadening the clinical view of ADHD.
- WorkshopPre-Conference Workshop: SleepRolling in the Deep of Sleep: Neurotransmitters, Architecture, and Practical Diagnosis
Reviews the neurobiology of sleep-wake circuits and sleep architecture, and offers a practical framework for diagnosing sleep disorders.
- WorkshopPre-Conference Workshop: SleepThe Fate of Orexins: Their Expanding Role in Insomnia, Hypersomnia, and Depression
Covers orexin system physiology and the growing therapeutic role of orexin receptor antagonists and agonists across insomnia, hypersomnia, and mood disorders.
- WorkshopPre-Conference Workshop: SleepHow It's Done: Practical Case-Based Strategies for Sleep Disorders
Case-based walkthrough of real-world treatment decisions for common sleep disorders.
- SymposiumSwitching Gears in MDD: When, Why, and How to Use Glutamatergic Therapies to Optimize Functional Outcomes
Andrew J. Cutler · Kristian Dambrino
When and how to deploy glutamatergic agents in major depressive disorder to improve functional recovery.
- SymposiumChallenge Accepted: Strategies to Overcome Difficult-to-Treat Depression
Treatment strategies for depression that has not responded to standard approaches.
- SymposiumEfficacy, Acceptability, and Accessibility and Accessibility of SDA-PAs: Shared Decision Making in the Selection and Sequencing of Treatments for MDD
Roger S. McIntyre · Thomas L. Schwartz
Applies shared decision-making to selecting and sequencing serotonin-dopamine activity partial agonists among MDD treatment options. Title reproduced exactly as published on the agenda.
- SymposiumGaining Insight Into Anosognosia as a Barrier to Treatment of Schizophrenia Spectrum Disorders
Examines impaired illness awareness in schizophrenia spectrum disorders and its impact on engagement and treatment adherence.
- SymposiumTime Is Brain: Early Adoption of Long-Acting Injectables to Improve Functional Outcomes in Serious Mental Illness
Makes the case for earlier use of long-acting injectable antipsychotics in serious mental illness, with shared decision-making strategies.
Antipsychotic PrescribingLong-Acting InjectablesSerious Mental Illness
- WorkshopPre-ConferenceSleep Workshop
A pre-conference workshop on diagnosing and treating sleep disorders in psychiatric patients, covering sleep neurobiology, diagnostic screening and testing, and combined pharmacologic and behavioral treatment.
Measurement-Based Care & DiagnosisNeuroscience & MechanismsSleep & Insomnia
November 6, 2026
- 07:00–08:00SessionIndustry SessionBreakfast Industry Session†: Alcohol Use Detectives: Following the Clues of Alcohol Use Disorder
Arwen Podesta · David Shaker · Martin Clarke
Industry-sponsored breakfast session on recognizing and approaching alcohol use disorder in clinical practice.
- 10:30–11:15SessionIndustry SessionMorning Industry Session†: Approach MDD Differently: EXXUA (gepirone) for the treatment of adults with MDD
Industry-sponsored session on gepirone for adults with major depressive disorder.
- 12:30–13:30SessionIndustry SessionLunch Industry Session†: Learn about a psychiatric medicine with two FDA-approved uses
Industry-sponsored lunch session on a psychiatric medicine with two FDA-approved indications.
- 12:30–13:30SessionIndustry SessionLunch Industry Session†: COBENFYCast LIVE!™: Front Row to the Patient, Care Partner, and Prescriber Voices
Gus Alva · Fines Shaw · Chanel · Areli
Live industry-sponsored session featuring patient, care partner, and prescriber perspectives on xanomeline-trospium.
- 14:50–15:05PanelTD Panel Q&A
Leslie Citrome · Hara E. Oyedeji
Question-and-answer panel on tardive dyskinesia recognition and treatment.
- 15:20–16:05SessionIndustry SessionAfternoon Industry Session†: Treating Excessive Daytime Sleepiness due to OSA: Translating Clinical Trial Endpoints Into Practice
Industry-sponsored session on treating excessive daytime sleepiness due to obstructive sleep apnea and applying trial endpoints in practice.
- 18:45–19:45SessionIndustry SessionDinner Industry Session†: Inspired by Patients, Driven by Science: The Neurocrine Story
Dimitri E. Grigoriadis · Christopher F. O’Brien
Industry-sponsored dinner session on the company's research and development story.
- SymposiumThe Clinical Promise of Muscarinic Agonists: Why, When, and How Across Neuropsychiatric Disorders
Reviews the mechanism and clinical positioning of muscarinic agonists across neuropsychiatric conditions.
- SymposiumFrom "Anxious" to Accurate: Neurobiology, Diagnostic Clarity, and Emerging Directions in Generalized Anxiety Disorder
Sharpens the diagnosis of generalized anxiety disorder and surveys its neurobiology and emerging treatment directions.
- SymposiumMore Than Meets the Eye: Transforming Care for Depression Across Bipolar Spectrum Disorders
Addresses recognition and treatment of depressive and mixed presentations across the bipolar spectrum.
- SymposiumSeen and Unseen: The Hidden Toll of Tardive Dyskinesia
Explores the functional and psychosocial burden of tardive dyskinesia and how to screen, assess, and monitor for it.
- SessionAIMS Demonstration
Leslie Citrome · Hara E. Oyedeji
Live demonstration of how to administer the Abnormal Involuntary Movement Scale in practice.
Measurement-Based Care & DiagnosisTardive Dyskinesia & Movement Disorders
- SymposiumSteady Hands, Steady Minds: From Evidence to Empowerment in TD Treatment
Reviews the neurobiological rationale and clinical evidence behind current tardive dyskinesia treatments.
Tardive Dyskinesia & Movement DisordersNeuroscience & Mechanisms
- SymposiumLetting Go: The Art and Science of Deprescribing in Psychiatry
Jeffrey Robert Strawn · Stephen M. Stahl
Practical guidance on when and how to taper or discontinue psychiatric medications safely.
November 7, 2026
- 07:00–08:00SessionIndustry SessionBreakfast Industry Session†: An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia
Industry-sponsored breakfast session on an established treatment option for bipolar I disorder and schizophrenia.
- 08:15–09:15LectureReproductive Mood Disorders Across the Life Cycle
Covers how reproductive hormonal transitions influence mood, from PMS and PMDD through postpartum and perimenopausal symptoms. Reviews treatment options including lifestyle, serotonergic, hormonal and newer agents.
DepressionNovel AntidepressantsPerinatal & Women's Mental Health
- 09:20–10:05SessionIndustry SessionMorning Industry Session†: Advancing Pediatric ADHD Management: The Role of the Only Liquid Non-Stimulant Therapy
Industry-sponsored session on a liquid non-stimulant option in pediatric ADHD management.
- 12:20–13:20SessionIndustry SessionLunch Industry Session†: Mixed Features and Anxious Distress Specifiers: Clinical Implications and a Treatment Option in Adjunctive MDD and Bipolar I and II Depression
Industry-sponsored lunch session on mixed features and anxious distress specifiers in MDD and bipolar depression and an adjunctive treatment option.
- 12:20–13:20SessionIndustry SessionLunch Industry Session†: Impact, Assessment, and Treatment of Tardive Dyskinesia: A Focus on Patient-Reported Outcomes With a VMAT2 Inhibitor
Christoph U. Correll · Chelsie Monroe
Industry-sponsored lunch session on tardive dyskinesia assessment and treatment with a VMAT2 inhibitor, focusing on patient-reported outcomes.
- 14:40–15:40PosterCE & Non-CE Scientific Poster Reception
- 16:50–17:50LectureNo One is Getting Younger: ADHD in Older Adults
Addresses recognizing ADHD in older adults and distinguishing it from mild cognitive impairment, dementia and other causes of cognitive decline. Covers diagnostic tools and treatment prioritization when conditions coexist.
- SymposiumHormones Gone Wild? Depression Across the Female Lifespan From Puberty to Perimenopause
Examines hormonally influenced depression across reproductive stages from puberty through perimenopause.
- SymposiumResidual Symptoms in ADHD: From Circuitry to Clinical Strategy
Jeffrey Robert Strawn · Andrew J. Cutler
Links residual ADHD symptoms to underlying circuitry and offers strategies to optimize treatment response.
- SymposiumADHD in Older Adults
- SymposiumThere's No Place Like Home: Practical Strategies to Manage Agitation in Alzheimer's Disease and Support Caregivers
Practical management of agitation in Alzheimer's disease alongside strategies to support caregivers.
- SymposiumSuicide Prevention
- SymposiumTelehealth on Trial: Lessons From the Done.com Case for Safe and Ethical Prescribing
David W. Goodman · Andrew J. Cutler
Draws lessons from the Done.com telehealth prosecution for safe, ethical controlled-substance prescribing via telepsychiatry.
Digital Psychiatry & AIPractice, Policy & WorkforceStimulants & ADHD Medications
November 8, 2026
- 07:00–08:00SessionIndustry SessionBreakfast Industry Session†: Changing the Tune in TRD: Exploring Neurobiology and Navigating Care Pathways
Sandhya Prashad · Bryan Shapiro · Saundra Jain
Industry-sponsored breakfast session on the neurobiology of treatment-resistant depression and pathways for navigating patient care.
Neuroscience & MechanismsPsychedelicsTreatment-Resistant Depression
- 08:15–09:15LectureFrom Breakthrough to Scrutiny: Promise, Proof, and the Path to Practice for Psychedelic Therapeutics
Critical appraisal of the evidence for psychedelic therapies including psilocybin and MDMA, with attention to trial design pitfalls and practical readiness for clinical implementation.
Drug Pipeline & Clinical TrialsPsychedelicsPTSD & TraumaTreatment-Resistant Depression
- 11:30–12:30PanelThe Dating Game: Swipe Right on Psychopharmacology and Meet the Mystery Bachelor Meds
Christoph U. Correll · Roger S. McIntyre · Hara E. Oyedeji · Thomas L. Schwartz
Game-style interactive session in which faculty present psychiatric medications for audience guessing and discussion.
- 12:45–13:45SessionIndustry SessionLunch Industry Session†: Advancing LAI Conversations in Schizophrenia Treatment: The LAI-CARE Tool
John M. Kane · Delbert G. Robinson
Industry-sponsored lunch session on facilitating long-acting injectable conversations in schizophrenia using the LAI-CARE tool.
- SymposiumPsychedelics
- SymposiumOld Time Pharmaco: Contemporary Evidence for Retiring Older Therapies and Optimizing Clozapine and Lithium Use
Reviews older psychotropics with limited modern utility and current best practices for clozapine and lithium.
ClozapineDeprescribing & PolypharmacyLithium & Mood Stabilizers
- SymposiumFrom Stigma to Superpower: Reframing Mental Health Disorders Through Creativity and Contribution
Andrew J. Cutler · Roger S. McIntyre
Explores reframing mental illness by highlighting creativity and societal contribution of people with psychiatric conditions.
- SessionDating Game
Schedule to be announced
- 13:00–18:00CourseChild AcademyChild & Adolescent Psychiatry Academy Sessions
Academy sessions on child and adolescent psychiatry; separate registration is required.
- WorkshopPre-Conference ProgramsPre-Conference Workshop: Sleep
Pre-conference workshop on sleep, offered as an add-on to the NEI Fall Congress.
Never miss an early-bird deadline
One-click alerts for this conference — we email you 14 and 3 days before each deadline:
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Chicago (5)
- Illinois (5)
- San Diego (5)
- Colorado (4)
- Florida (4)
- Denver (3)
- Louisiana (3)
- New Orleans (3)
- New Zealand (3)
- Reston (3)
- Texas (3)
- Virginia (3)
- Austin (2)
- Australia (2)
- Hawaii (2)
- New York (2)
- Orlando (2)
- Washington (2)
- Washington, D.C. (2)
- Adelaide (1)
- Albuquerque (1)
- Arizona (1)
- Asheville (1)
- Atlanta (1)
- Auckland (1)
- Bahamas (1)
- Baltimore (1)
- Barcelona (1)
- Boston (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Cartagena (1)
- Christchurch (1)
- Cincinnati (1)
- Colombia (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Georgia (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Massachusetts (1)
- Minneapolis (1)
- Minnesota (1)
- Montreal (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- North Carolina (1)
- Ohio (1)
- Paradise Island (1)
- Queenstown (1)
- Rio de Janeiro (1)
- San Francisco (1)
- Scottsdale (1)
- South Africa (1)
- Spain (1)
- Tennessee (1)
- Thredbo Village (1)
- United Kingdom (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry